Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Developmental and reproduction toxicity of piperonyl butoxide part 1 developmental safety of piperonyl butoxide in the CD® (Sprague Dawley) rat.

Authors:
Alan M Hoberman Judith W Hauswirth

Reprod Toxicol 2022 Aug 2;112:171-176. Epub 2022 Aug 2.

Hauswirth Consulting, Inc., 3222 Green Forest Ct., Ellicott City, MD 21042, USA. Electronic address:

Developed as an insecticide synergist in the early 1940s, PBO increases the effectiveness of pyrethrins. Herein, the findings from a guideline developmental toxicity study in rat conducted in 1991 are reported. Timed-pregnant CD® (Sprague Dawley) rats were randomly assigned to a control and three treatment groups of 25 females each. A single daily dose of 200, 500 and 1000 mg/kg/day was administered orally (gavage) on days 6-15 of gestation. A vehicle group received deionized water. Cesarean sections were performed on all surviving females on gestation day 21 and fetuses were evaluated. All rats survived to GD 21 of gestation. Pregnancy rates in each group ranged from 88 % to 96 %. One dam in the 500 mg/kg/day dose had a single conceptus litter (one early resorption). Adverse clinical observations (urogenital wetness and staining) occurred in the 1000 mg/kg/day dose group. Maternal body weight decrease and food reductions occurred over the dosing period in the 500 and 1000 mg/kg/day groups. There were no treatment-related maternal necropsy findings. Terminal body weights and gravid uterine weights were comparable among the groups. Corrected body weight gain was decreased (>10 %) at 500 and 1000 mg/kg/day. Increased liver weights and relative liver weights were observed in the 1000 mg/kg/day dose group. There were no treatment-related effects on early resorptions, late resorptions, live fetuses per litter or sex ratio, or fetal weight per litter among the dose groups and no fetal malformations or variations attributed to PBO at any dose level.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.reprotox.2022.07.010DOI Listing
August 2022

Publication Analysis

Top Keywords

500 1000 mg/kg/day
12
sprague dawley
8
1000 mg/kg/day dose
8
piperonyl butoxide
8
body weight
8
dose group
8
liver weights
8
cd® sprague
8
dose
6
1000 mg/kg/day
5
dose level
4
terminal body
4
group received
4
findings terminal
4
received deionized
4
necropsy findings
4
treatment-related maternal
4
deionized water
4
maternal necropsy
4
water cesarean
4

Keyword Occurance

Similar Publications

2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial.

Authors:
Anant Narayan Bhatt Srinivas Shenoy Sagar Munjal Vijayakumar Chinnadurai Apurva Agarwal A Vinoth Kumar A Shanavas Ratnesh Kanwar Sudhir Chandna

BMC Infect Dis 2022 Aug 4;22(1):669. Epub 2022 Aug 4.

Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization, Timarpur, Delhi, 110054, India.

Background: At present, no single efficacious therapeutic exists for acute COVID-19 management and a multimodal approach may be necessary. 2-deoxy-D-glucose (2-DG) is a metabolic inhibitor that has been shown to limit multiplication of SARS-CoV-2 in-vitro. We evaluated the efficacy and safety of 2-DG as adjunct to standard care in the treatment of moderate to severe COVID-19 patients. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Developmental and reproduction toxicity of piperonyl butoxide part 1 developmental safety of piperonyl butoxide in the CD® (Sprague Dawley) rat.

Authors:
Alan M Hoberman Judith W Hauswirth

Reprod Toxicol 2022 Aug 2;112:171-176. Epub 2022 Aug 2.

Hauswirth Consulting, Inc., 3222 Green Forest Ct., Ellicott City, MD 21042, USA. Electronic address:

Developed as an insecticide synergist in the early 1940s, PBO increases the effectiveness of pyrethrins. Herein, the findings from a guideline developmental toxicity study in rat conducted in 1991 are reported. Timed-pregnant CD® (Sprague Dawley) rats were randomly assigned to a control and three treatment groups of 25 females each. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Experiences of performing ABO-incompatible kidney transplantation in Bangladesh.

Authors:
Nura Afza Salma Begum Tasnuva Sarah Kashem Farnaz Nobi Shakib Uz-Zaman Arefin Harun Ur Rashid

Korean J Transplant 2022 Jun;36(2):111-118

Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.

Background: The number of end-stage renal disease (ESRD) patients is increasing in Bangladesh. Currently, living kidney donation is the only viable option for transplantation in Bangladesh, and it is further restricted by ABO compatibility issues. We have performed ABO-incompatible kidney transplantations (ABOi KTs) in Bangladesh since 2018. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders.

Authors:
Joanna K Winstone Khyatiben V Pathak Wendy Winslow Ignazio S Piras Jennifer White Ritin Sharma Matthew J Huentelman Patrick Pirrotte Ramon Velazquez

J Neuroinflammation 2022 Jul 28;19(1):193. Epub 2022 Jul 28.

Arizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, Arizona State University, 797 E Tyler St, Tempe, AZ, 85287, USA.

Background: Herbicides are environmental contaminants that have gained much attention due to the potential hazards they pose to human health. Glyphosate, the active ingredient in many commercial herbicides, is the most heavily applied herbicide worldwide. The recent rise in glyphosate application to corn and soy crops correlates positively with increased death rates due to Alzheimer's disease and other neurodegenerative disorders. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.

Authors:
Qi Xin Wei Lv Yunxi Xu Yumei Luo Caifang Zhao Bichen Wang Miaomiao Yuan Huanping Li Xiaoxia Song Tao Jing

PLoS Negl Trop Dis 2022 07 18;16(7):e0010618. Epub 2022 Jul 18.

Department of Pathogenic Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

2-Deoxy-D-glucose (2-DG) is a glucose analog used as a promising anticancer agent. It exerts its effects by inhibiting the glycolytic energy metabolism to deplete cells of energy. The larval stage of Echinococcus relies on glycolysis for energy production. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}